Today: 7 February 2026
Subscribe

Tesco PLC stock today: TSCO shares edge up in London — what traders are watching next

Tesco PLC stock today: TSCO shares edge up in London — what traders are watching next

Tesco shares rose 0.5% to 417.5 pence in early London trading Monday after a volatile post-Christmas stretch. The company’s UK like-for-like sales grew 3.2% over Christmas, but volume trends remain under scrutiny as price competition intensifies. Tesco bought back 475,248 shares last week as part of its £1.45 billion repurchase program. Investors await UK inflation data and Tesco’s April earnings report.
12 January 2026
·
Unilever stock rises in London as banks slide, investors lean defensive

Unilever stock rises in London as banks slide, investors lean defensive

Unilever shares rose 0.8% to 4,783.5 pence by 0840 GMT, near session highs, after the company reaffirmed its 2025 sales and margin outlook following its ice cream spin-off. European stocks slipped, with the STOXX 600 down 0.2% as banks fell sharply after U.S. President Trump announced a cap on credit card rates. Unilever will report Q4 and full-year 2025 results on Feb. 12.
12 January 2026
GSK stock in focus: JPMorgan healthcare agenda, merger chatter and key dates for investors

GSK stock in focus: JPMorgan healthcare agenda, merger chatter and key dates for investors

GSK shares slipped 0.03% to 1,885.5 pence in early London trading Monday, as investors awaited the company’s appearance at the J.P. Morgan Healthcare Conference in San Francisco on Tuesday. GSK’s ADRs closed up 0.3% in the U.S. at $50.39. Traders are watching for updates ahead of GSK’s full-year results due February 4.
12 January 2026
····
BP PLC stock nudges up as Iran unrest props oil, but Goldman flags a 2026 glut

BP PLC stock nudges up as Iran unrest props oil, but Goldman flags a 2026 glut

BP shares rose 0.35% to 427.1 pence in early London trading Monday, tracking a modest uptick in oil prices. Brent crude edged up to $63.39 a barrel as unrest in Iran fueled supply concerns, while Venezuelan output limits capped gains. Goldman Sachs maintained a $56 Brent forecast for 2026, citing a projected surplus. BP will report fourth-quarter results and its dividend on Feb. 10.
12 January 2026
··
Anglo American stock hits a new 52-week high — what’s driving AAL and what to watch next

Anglo American stock hits a new 52-week high — what’s driving AAL and what to watch next

Anglo American shares rose 1.7% to 3,270p in early London trading Monday, touching a new 52-week high amid renewed merger speculation in the mining sector. The European Commission is set to rule on the Anglo-Teck merger by Feb. 10, with a separate decision on foreign subsidies due Feb. 3. Anglo’s Q4 production report is scheduled for Feb. 5, and full-year results on Feb. 20.
12 January 2026
···
Shell stock today: SHEL.L ticks up as oil headlines clash with buyback doubts

Shell stock today: SHEL.L ticks up as oil headlines clash with buyback doubts

Shell shares rose 0.3% to 2,647.5 pence in early London trading Monday as investors weighed oil market volatility and concerns over the company’s Chemicals and Products division loss in Q4. Shell continued its $3.5 billion buyback program, purchasing nearly 2 million shares last week for cancellation. Brent crude traded at $63.39 a barrel amid supply risks from Iran and Venezuela.
12 January 2026
··
Diageo shares rise as Kenya court keeps $2.3bn Asahi deal moving

Diageo shares rise as Kenya court keeps $2.3bn Asahi deal moving

Diageo shares rose about 1.4% in early London trading after a Kenyan court allowed regulatory reviews to proceed on its planned $2.3 billion sale of East African Breweries to Asahi. The court paused the deal’s final steps until Jan. 20. The case stems from a challenge by Bia Tosha Distributors. Diageo will report interim results on Feb. 25.
12 January 2026
··
Rio Tinto stock faces Glencore merger countdown as BHP speculation builds

Rio Tinto stock faces Glencore merger countdown as BHP speculation builds

Rio Tinto confirmed early-stage merger talks with Glencore, sending its London shares down 3.04% to 6,006 pence Friday. The miner said any deal could use a UK “scheme of arrangement” but stressed no offer is certain. BHP is seen as a possible rival bidder as copper demand drives consolidation. Rio faces a Feb. 5 deadline under UK takeover rules.
12 January 2026
····
Compass Group stock nudges up as dividend date nears — here’s what could move CPG next

Compass Group stock nudges up as dividend date nears — here’s what could move CPG next

Compass Group shares rose 0.7% to 2,362 pence in early London trading Monday, ahead of the Jan. 15 ex-dividend date and a Feb. 5 AGM and trading update. The stock remains about 17% below its 52-week high. Broader markets were volatile as Fed Chair Jerome Powell said the Trump administration threatened him with indictment, sending the dollar lower and gold above $4,600 an ounce.
12 January 2026
··
1 … 440 441 442 443 444 … 1,631

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop